These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20728271)

  • 1. Multicomponent reaction models in ozonation and reduction in the number of model parameters.
    Kuosa M; Kallas J
    J Hazard Mater; 2010 Nov; 183(1-3):823-32. PubMed ID: 20728271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifiability of parameters and behaviour of MCMC chains: a case study using the reaction norm model.
    Shariati MM; Korsgaard IR; Sorensen D
    J Anim Breed Genet; 2009 Apr; 126(2):92-102. PubMed ID: 19320765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical analysis of chemical transformation kinetics using Markov-Chain Monte Carlo methods.
    Görlitz L; Gao Z; Schmitt W
    Environ Sci Technol; 2011 May; 45(10):4429-37. PubMed ID: 21526818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markov chain models and estimation of absolute progression rates: application to cataract progression in diabetic adults.
    Prevost TC; Rohan TE; Duffy SW; Chen HH; To T; Hill RD
    J Epidemiol Biostat; 1999; 4(4):337-44. PubMed ID: 10764248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascertainment correction for Markov chain Monte Carlo segregation and linkage analysis of a quantitative trait.
    Ma J; Amos CI; Warwick Daw E
    Genet Epidemiol; 2007 Sep; 31(6):594-604. PubMed ID: 17487893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifiability of parameters in MCMC Bayesian inference of phylogeny.
    Rannala B
    Syst Biol; 2002 Oct; 51(5):754-60. PubMed ID: 12396589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard.
    Toft N; Innocent GT; Gettinby G; Reid SW
    Prev Vet Med; 2007 May; 79(2-4):244-56. PubMed ID: 17292499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and (eco) toxicological assessment of batch partial ozone oxidation and subsequent biological treatment of a tank truck cleaning generated concentrate.
    De Schepper W; Dries J; Geuens L; Robbens J; Blust R
    Water Res; 2009 Sep; 43(16):4037-49. PubMed ID: 19592066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient computation of transient solutions of the chemical master equation based on uniformization and quasi-Monte Carlo.
    Hellander A
    J Chem Phys; 2008 Apr; 128(15):154109. PubMed ID: 18433192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of alternative MCMC strategies illustrated using the reaction norm model.
    Shariati M; Sorensen D
    J Anim Breed Genet; 2008 Jun; 125(3):176-86. PubMed ID: 18479268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of biological kinetic parameters from a continuous integrated ozonation-activated sludge system treating domestic wastewater.
    Beltrán FJ; García-Araya JF; Alvarez PM
    Biotechnol Prog; 2000; 16(6):1018-24. PubMed ID: 11101329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparametric identification of population models: an MCMC approach.
    Neve M; De Nicolao G; Marchesi L
    IEEE Trans Biomed Eng; 2008 Jan; 55(1):41-50. PubMed ID: 18232345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering mental representations with Markov chain Monte Carlo.
    Sanborn AN; Griffiths TL; Shiffrin RM
    Cogn Psychol; 2010 Mar; 60(2):63-106. PubMed ID: 19703686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment.
    Abbas I; Rovira J; Casanovas J
    Contemp Clin Trials; 2007 May; 28(3):220-31. PubMed ID: 16979387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ozonation of Procaine Penicillin G formulation effluent Part I: Process optimization and kinetics.
    Arslan-Alaton I; Caglayan AE
    Chemosphere; 2005 Mar; 59(1):31-9. PubMed ID: 15698641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring heterogeneity in tumour data using Markov chain Monte Carlo.
    de Gunst MC; Dewanji A; Luebeck EG
    Stat Med; 2003 May; 22(10):1691-707. PubMed ID: 12720305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCMC estimation for the p(2) network regression model with crossed random effects.
    Zijlstra BJ; van Duijn MA; Snijders TA
    Br J Math Stat Psychol; 2009 Feb; 62(Pt 1):143-66. PubMed ID: 19208289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity analysis of an urban stormwater microorganism model.
    McCarthy DT; Deletic A; Mitchell VG; Diaper C
    Water Sci Technol; 2010; 62(6):1393-400. PubMed ID: 20861555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCMC for hidden Markov models incorporating aggregation of states and filtering.
    Rosales RA
    Bull Math Biol; 2004 Sep; 66(5):1173-99. PubMed ID: 15294422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.